Featured Research

from universities, journals, and other organizations

Researchers Find New Pathway To Brain Cell Suicide

Date:
April 9, 1999
Source:
Washington University School Of Medicine
Summary:
Scientists have long known that a brain chemical called glutamate can be deadly to neurons when it floods out of cells damaged by head injury and stroke. Excessive amounts of glutamate kill neurons by interacting with cell-surface proteins such as the NMDA receptor. The important role of this glutamate receptor in neuronal necrosis due to excessive calcium influx is well understood. But recent evidence has suggested that the NMDA receptor also may trigger cell suicide (programmed cell death, also called apoptosis), which is thought to enlarge damaged areas of the brain, lessening patients’ chance of survival.

St. Louis, April 9, 1999 – Scientists have long known that a brain chemical called glutamate can be deadly to neurons when it floods out of cells damaged by head injury and stroke. Excessive amounts of glutamate kill neurons by interacting with cell-surface proteins such as the NMDA receptor. The important role of this glutamate receptor in neuronal necrosis due to excessive calcium influx is well understood. But recent evidence has suggested that the NMDA receptor also may trigger cell suicide (programmed cell death, also called apoptosis), which is thought to enlarge damaged areas of the brain, lessening patients’ chance of survival. But until now, there has been no information about how activation of glutamate receptors may induce apoptosis.

In a study described in today’s Science, researchers at Washington University School of Medicine in St. Louis exposed brain cells and tissue to conditions that mimic those after stroke. They observed a flow of potassium ions out of the neurons, and this flow ebbed when they inactivated the NMDA receptor. Moreover, neurons that lost potassium committed suicide during the following days.

"This work provides evidence that potassium efflux through glutamate receptor channels may be one of the mechanisms that mediate programmed cell death of neurons," says lead author Shan Ping Yu, M.D., Ph.D., research associate professor of neurology. "And it is the first study to identify a consequence of potassium efflux through NMDA receptors."

Whereas necrotic cells swell up and burst, suicidal cells shrink into oblivion. A shrinking cell must be losing ions and water, Yu deduced, focusing on potassium because of its high concentration in cells. Although potassium was known to flow through voltage-gated potassium channels and the channel controlled by the NMDA receptor, the contribution of potassium movement through NMDA receptor channels to disease or normal physiology had not previously been studied.

Dennis W. Choi, M.D., Ph.D., the Andrew B. and Gretchen P. Jones Professor and head of neurology, directed the research team, and his long-time interests in the NMDA receptor and cell death initiated the current study. "These findings suggest that the participation of NMDA receptors in the pathogenesis of brain injury may be more multidimensional than previously suspected, and thus they increase the therapeutic rationale for developing drugs capable of blocking NMDA receptors," Choi says.

In the study, Yu made the first direct measurements of NMDA-evoked potassium currents from cortical neurons. The research team then looked at neurons cultured with glia, the brain’s housekeeping cells. When extracellular levels of sodium and calcium mimicked those in the healthy brain, NMDA (a glutamate-like chemical) killed the neurons by necrosis. But when sodium and calcium levels were low, as after brain injury, adding NMDA triggered apoptosis during the next one to two days. A chemical that blocks the action of NMDA inhibited both the cellular depletion of potassium and apoptosis, as did raising the concentration of potassium in the medium. According to Yu and other researchers, cellular potassium reduction may be a key step in activating apoptotic genes such as caspases. "This study provides evidence that the NMDA receptor may promote apoptosis by allowing potassium to escape from neurons," says Yu.

Next, the research team demonstrated that endogenous glutamate release also could cause neurons to lose potassium and undergo apoptosis if extracellular sodium and calcium levels were low. It appears, therefore, that glutamate released from brain cells can rob neighboring cells of potassium, facilitating their demise by programmed cell death.

"This work has opened a door for us to understand how and why glutamate triggers cell suicide after an ischemic insult," Yu says. "It eventually may provide a new opportunity to prevent or attenuate brain damage after harmful events such as stroke."

###

Grants from the National Institutes of Health supported this research.

Yu SP, Yeh C-H, Strasser U, Tian M, Choi DW. NMDA receptor-mediated K+ efflux and neuronal apoptosis. Science vol. 284, April 9, 1999.


Story Source:

The above story is based on materials provided by Washington University School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Washington University School Of Medicine. "Researchers Find New Pathway To Brain Cell Suicide." ScienceDaily. ScienceDaily, 9 April 1999. <www.sciencedaily.com/releases/1999/04/990409072029.htm>.
Washington University School Of Medicine. (1999, April 9). Researchers Find New Pathway To Brain Cell Suicide. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/1999/04/990409072029.htm
Washington University School Of Medicine. "Researchers Find New Pathway To Brain Cell Suicide." ScienceDaily. www.sciencedaily.com/releases/1999/04/990409072029.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins